IP Library Granted Patent US 7,230,093
Granted Patent B2
US 7,230,093 · App. 10/755,921 · Granted Jun 12, 2007

Method of sequencing by hybridization of oligonucleotide probes

Assignee: Callida Genomics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,230,093
App. No.
10/755,921
Granted
Jun 12, 2007
Kind
B2
Abstract

The conditions under which oligonucleotide probes hybridize preferentially with entirely complementary and homologous nucleic acid targets are described. Using these hybridization conditions, overlapping oligonucleotide probes associate with a target nucleic acid. Following washes, positive hybridization signals are used to assemble the sequence of a given nucleic acid fragment. Representative target nucleic acids are applied as dots. Up to to 100,000 probes of the type (A,T,C,G)(A,T,C,G)NB(A,T,C,G) are used to determine sequence information by simultaneous hybridization with nucleic acid molecules bound to a filter. Additional hybridization conditions are provided that allow stringent hybridization of 6–10 nucleotide long oligomers which extends the utility of the invention. A computer process determines the information sequence of the target nucleic acid which can include targets with the complexity of mammalian genomes. Sequence generation can be obtained for a large complex mammalian genome in a single process.

Claims (10)

1. A plurality of oligonucleotides capable of hybridizing to complementary DNA or RNA, each oligonucleotide in the plurality comprising an informative region of predetermined sequence and consisting of at least 6 nucleotides, said plurality comprising a majority of or all possible informative regions of a given length.

2. The plurality of oligonucleotides of claim 1 , wherein said oligonucleotides have non-informative bases on one or both ends.

3. The plurality of oligonucleotides of claims 1 or 2 , wherein said oligonucleotides have at least one nucleotide analog or at least one base analog.

4. A plurality of oligonucleotides capable of hybridizing to complementary DNA or RNA, each oligonucleotide in the plurality comprising an informative region of predetermined sequence and consisting of at least 6 nucleotides, said plurality comprising more than 4000 oligonucleotides.

5. The plurality of oligonucleotides of claim 4 , wherein the oligonucleotides have non-informative bases on one or both ends.

6. The plurality of oligonucleotides of claims 4 or 5 , wherein the oligonucleotides have at least one nucleotide analog or at least one base analog.

7. A plurality of oligonucleotides capable of hybridizing to complementary DNA or RNA, each having a predetermined sequence and a predetermined length, each oligonucleotide having a continuous sequence of at least five bases at its terminus overlapping with at least one other oligonucleotide at its opposite terminus in the plurality of oligonucleotides.

8. The plurality of oligonucleotides of claim 7 , wherein the oligonucleotides are at least 6 nucleotides in length.

9. The plurality of oligonucleotides of claim 7 , wherein said continuous overlapping sequence is at least 5 nucleotides in length.

10. The plurality of oligonucleotides of claims 7 , 8 or 9 , wherein the oligonucleotides have at least one nucleotide analog or at least one base analog.

Assignments (2)
SECURITY AGREEMENT Recorded Dec 14, 2004
From: CALLIDA GENOMICS, INC.
To: NUVELO, INC.; AFFYMETRIX, INC.
Reel/Frame 015442/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2004
From: DRMANAC, RADOJE T; CRKVENJAKOV, RADOMIR
To: CALLIDA GENOMICS, INC.
Reel/Frame 014817/0100 →
Priority Claims (2)
YU P-570/87 · Apr 11, 1987 · national
YU 18617/87-P-570/87 · Sep 13, 1987 · national
Continuity (9)
Division 0995442600 · Sep 10, 2001
Continuation 0920586500 · Dec 4, 1998
Continuation 0882053400 · Mar 19, 1997
Continuation 0846085300 · Jun 5, 1995
Continuation 0820350200 · Feb 28, 1994
Continuation 0804815200 · Apr 15, 1993
Continuation 0757655000 · Aug 31, 1990
Continuation 0717508800 · Mar 30, 1988
Related Publication 20040235013A1 · Nov 25, 2004